- when there is risk of torsades de pointes, for example in patients with prolonged QT, concomitant administration of other medications that produce torsades de pointes (amiodarone, quinidine, bepridil, IV erythromycin, halofrantine, pentamidine, sparfloxacin, sultopride, vincamine, betrilio, disopyramide, sotalol, etc)
Proper dosing is essential for managing this condition
The dosing below draws from the per-component research and aligns with both the FDA review documents for each peptide and PeptideFoxs previous research
When kidney function declines, clearance slows and the level drifts upwards
Does the injectable form need to be reconstituted
It solved my problem of having to discard unused solutions too quickly, saving us a lot of resources